Baker McKenzie advised CLSA Limited and other underwriters in the deal. Joincare Pharmaceutical executed a GDR listing on SIX Swiss Exchange Joincare Pharmaceutical is an innovation-driven integrated...
Joincare Pharmaceutical’s GDR listing on SIX Swiss Exchange
Leonteq’s Cooperation with VP Bank AG
Baker McKenzie advised Leonteq on the deal. Leonteq Securities AG signed a cooperation agreement with VP Bank AG for the manufacturing and distribution of structured investment products...
Zur Rose Group’s CHF 95 Million Convertible Bonds Offering and CHF 44 Million Capital Increase
Baker McKenzie advised Zur Rose on the offering. Advestra advised Goldman Sachs, UBS and BofA Securities. Zur Rose Group AG executed the placement of convertible bonds...
Feintool’s CHF 202 Million Rights Offering
Baker McKenzie advised Feintool International Holding AG on the deal. Niederer Kraft Frey advised UBS and Zürcher Kantonalbank. Feintool International Holding AG executed a capital increase by...
Arsenal Capital Partners’ Acquisition of ATP Group
Schellenberg Wittmer advised Arsenal Capital Partners on the deal, in cooperation with Jones Day. Bär & Karrer advised Bregal, together with Latham & Watkins. Baker McKenzie...
Cicor Group’s Convertible Bond Offering
Baker McKenzie advised Cicor Group on all legal and tax aspects of the issuance. Cicor Technologies Ltd, Boudry executed the issuance of a five-year non-interest bearing mandatory...
VT5 Acquisition Company AG’s Initial Public Offering
Baker McKenzie advised VT5 Acquisition Company AG on the offering. Niederer Kraft Frey advised EFG Bank AG. Advestra advised Credit Suisse and UBS. VT5 Acquisition Company...
Roche Holding’s CHF19 Billion Bridge Financing Agreement
Baker McKenzie advised BNP Paribas and Deutsche Bank on the deal. Lenz & Staehelin acted as legal advisor to the Roche family pool. Bär & Karrer...
Basilea Pharmaceutica’s CHF 45.75 Million Shares Offering
Baker McKenzie advised Basilea Pharmaceutica Ltd. on all legal aspects of this PIPE transaction. Homburger advised the managers.Basilea Pharmaceutica Ltd. successfully completed a capital increase from authorized...